Effect of retinoids and 1,25(OH)₂ vitamin D₃ bound to their plasma transport proteins on growth and differentiation of HL-60 cells

References

• Breitman T R, Selonick S E, Collins S J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936–40
   PubMed Web of Science ®Google Scholar
• Breitman T R, Collins S J, Keene B R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000–4
   PubMed Web of Science ®Google Scholar
• Miyaura C, Abe E, Suda T, Kuroki T. Alternative differentiation of human promyelocytic leukemja cells (HL-60) induced selectively by retinoic acid and 1,25-dihydroxyvitamin D3. Cancer Res 1985; 45: 4244–8
   Google Scholar
• Mangelsdorf D J, Koeffler H P, Donaldson C A, Pike J W, Haussler M R. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocyte leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 1984; 98: 391–8
   PubMed Web of Science ®Google Scholar
• Munker R, Norman A, Koeffler H P. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 1986; 78: 424–30
   PubMed Web of Science ®Google Scholar
• Momoi T, Senoo H, Yoshikura H. Two stages of the differentiation of HL-60 cells induced by 1,25-dihydroxy vitamin D3, commitment by 1,25-dihydroxyvitamin D-, and promotion by DMSO. Bioscience Rep 1986; 6: 95–101
   Google Scholar
• Blomhoff R, Helgerud P, Rasmussen M, Berg T, Norum K R. In vivo uptake of chylomicron [3H]retinyl ester by rat liver. Evidence for retinol transfer from parenchymal to nonparenchymal cells. Proc Natl Acad Sci USA 1982; 79: 7326–30
   PubMed Web of Science ®Google Scholar
• Blomhoff R, Rasmussen M, Nilsson A, et al. Hepatic retinol metabolism: distribution of retinoids, enzymes and binding proteins in isolated rat liver cells. J Biol Chem 1985; 260: 13560–5
   PubMedGoogle Scholar
• Goodman D S. Plasma retinol-binding protein. The Retinoids, M B Sporn, A B Roberts, D S Goodman. Academic Press, Orlando, FL 1984; Vol. 2: 41–88
   Google Scholar
• Wathne K O, Norum K R, Smeland E, Blomhoff R. Retinol bound to physiological carrier molecules regulates growth and differentiation of myeloid leukemic cells. J Biol Chem 1988; 263: 8691–5
   Google Scholar
• Underwood B. Vitamin A in animal and human nutrition. The Retinoids I, M B Sporn, A B Roberts, D S Goodman. Academic Press, Orlando, FL 1984; 282–393
   Google Scholar
• Tang G W, Russel R M. Thirteen-cis-retinoic acid is an endogenous compound in human blood. FASEB J 1988; 2: A1094
   Google Scholar
• Clamon G, Chabot G G, Valeriote F, et al. Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid. Cancer Res 1985; 45: 1874–8
   PubMed Web of Science ®Google Scholar
• Goodman D S. Vitamin A transport and delivery and the mechanism of vitamin A toxicity. Retinoids: advances in basic research and therapy, C E Orfanos, O Braun-Falco, R M Farber, C Grupper, M K Polano, R Schuppli. Springer-Verlag, Berlin 1981; 31–9
   Google Scholar
• Bikle D D, Siiteri P K, Ryzen E, Haddad J G. Serum protein binding of 1,25-dihydroxyvitamin D3: a re-evaluation by direct measurement of free metabolite levels. J Clin Endocrin Metab 1985; 61: 969–75
   PubMed Web of Science ®Google Scholar
• Bouillon R, van Assche F A, van Baelen H, Heyns W, DeMoor P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D. J Clin Invest 1981; 67: 589–96
   PubMed Web of Science ®Google Scholar
• Cooke N E, Walgate J, Haddad J G. Human serum binding protein for vitamin D and its metabolites. I. Physico-chemical and immunological identification in human tissues. J Biol Chem 1979; 254: 5958–64
   Google Scholar
• Segal A W. Nitroblue-tetrazolium tests. Lancet 1974; ii: 1248–52
   Google Scholar
• Godal T, Henriksen A, Ruud E, Michaelsen T. Monoclonal human B-lymphocyte cells respond by DNA synthesis to anti-immunoglobulins in the presence of the tumour promotor TPA. Scand J Immunol 1982; 15: 167–73
   Google Scholar
• Deckelbaum R J, Eisenberg S, Fainaru M, Barenholz Y, Olivecrona T. In vitro production of human plasma low density lipoprotein-like particles. J Biol Chem 1979; 254: 6079–87
   PubMed Web of Science ®Google Scholar
• Blomhoff R, Drevon C A, Eskild W, Helgerud P, Norum K R, Berg T. Clearance of acetyl low density lipoprotein by rat liver endothelial cells. J Biol Chem 1984; 259: 8898–903
   PubMedGoogle Scholar
• McGuire B W, Chytil F. Three-step purification of retinol-binding protein from rat serum. Biochim Biophys Acta 1980; 621: 324–31
   Google Scholar
• Vahlqvist A, Nilsson S E, Peterson P A. Isolation of the human retinol binding protein by affinity chromatography. Eur J Biochem 1971; 20: 160–8
   Google Scholar
• Smith J E, Milch P O, Muto Y, Goodman D S. The plasma transport and metabolism of retinoic acid in the rat. Biochem J 1973; 132: 821–7
   PubMed Web of Science ®Google Scholar
• Heller J. Interactions of plasma retinol-binding protein with its receptor. J Biol Chem 1975; 250: 3613–9
   PubMed Web of Science ®Google Scholar
• Wathne K O, Calander B, Norum K R, Blomhoff R. Uptake of retinyl ester in HL-60 cells via the low-density-lipoprotein-receptor pathway. Biochem J 1989; 257: 239–44
   PubMedGoogle Scholar
• Lampkin B C, Woods W, Strauss R, et al. Current status on the biology and treatment of acute nonlymphocytic leukemia in children (report from the ANLL strategy group of the Children's Cancer Study Group). Blood 1983; 61: 215–28
   PubMed Web of Science ®Google Scholar
• Chessels J. Acute leukaemia in children. Clinics in Haematology, R P Gale, A V Hoffbrand. WB Saunders, Philadelphia 1986; 15: 727–53
   Google Scholar
• Flynn P J, Miller W J, Weisdorf D J, Arthur D C, Brunning R, Branda R F. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood 1983; 62: 1211–17
   PubMed Web of Science ®Google Scholar
• Nilsson B. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia. Br J Haematol 1984; 57: 365–71
   PubMed Web of Science ®Google Scholar
• Daenen S, Vellenga E, van Dobbenburgh O A, Halie M R. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and aspergillus pneumonia. Blood 1986; 67: 559–61
   PubMed Web of Science ®Google Scholar
• Fontana J A, Rogers J A, Durham J P. The role of 13 cis-retinoic acid in the remission inducation of a patient with acute promyelocytic leukemia. Cancer 1986; 57: 209–17
   PubMed Web of Science ®Google Scholar
• Huang M E, Ye Y C, Chen S R, Chai J R, Lu J X, Zhoa L, Gu L J, Wang Z Y. Use of M-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72
   PubMed Web of Science ®Google Scholar
• Lie S O, Wathne K O, Petersen L B, Slørdal S H, Norum K R. High-dose retinol in children with acute myelogenous leukemia in remission. Eur J Haematol 1988; 40: 460–5
   PubMed Web of Science ®Google Scholar